The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2024

Filed:

Jan. 22, 2021
Applicant:

Spiral Therapeutics Inc., Brisbane, CA (US);

Inventors:

Eugene de Juan, Brisbane, CA (US);

Signe Erickson, Brisbane, CA (US);

Charles Limb, Brisbane, CA (US);

Hugo Peris, Brisbane, CA (US);

Nikhil Talreja, Brisbane, CA (US);

Andrew Ayoob, Brisbane, CA (US);

Assignee:

Spiral Therapeutics Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 31/00 (2006.01); A61B 1/018 (2006.01); A61B 1/227 (2006.01); A61B 17/29 (2006.01); A61B 17/32 (2006.01); A61B 17/3205 (2006.01); A61B 17/34 (2006.01); A61B 18/04 (2006.01); A61B 18/14 (2006.01); A61B 18/20 (2006.01); A61F 2/958 (2013.01); A61F 11/20 (2022.01); A61M 37/00 (2006.01); G02B 21/00 (2006.01); G02B 21/22 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61F 2/18 (2006.01);
U.S. Cl.
CPC ...
G02B 21/0012 (2013.01); A61B 1/018 (2013.01); A61B 1/227 (2013.01); A61B 17/29 (2013.01); A61B 17/320068 (2013.01); A61B 17/3205 (2013.01); A61B 17/3423 (2013.01); A61B 17/3468 (2013.01); A61B 17/3478 (2013.01); A61B 18/04 (2013.01); A61B 18/1485 (2013.01); A61B 18/20 (2013.01); A61F 2/958 (2013.01); A61F 11/20 (2022.01); A61F 11/202 (2022.01); A61M 31/00 (2013.01); A61M 31/002 (2013.01); A61M 37/0015 (2013.01); G02B 21/0032 (2013.01); G02B 21/22 (2013.01); A61B 2017/00115 (2013.01); A61B 2017/00787 (2013.01); A61B 2017/00867 (2013.01); A61B 2017/32007 (2017.08); A61B 2018/00327 (2013.01); A61B 2217/005 (2013.01); A61F 2002/183 (2013.01); A61F 2250/0067 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01); A61M 2205/04 (2013.01); A61M 2210/0662 (2013.01); A61M 2210/0668 (2013.01);
Abstract

Intra-tympanic injections of therapeutics into the inner ear can be used to treat conditions such as hearing loss. One or more stabilizing devices that define working channels can be temporarily implanted in the tympanic membrane. Purpose-built instruments such as endoscopes, forceps, and injections instruments can be passed through the working channels of the stabilizer devices to access the inner ear where the therapy can be administered. Afterwards, the stabilizing devices can be removed from the tympanic membrane and the tympanic membrane can heal, typically without the need for sutures.


Find Patent Forward Citations

Loading…